Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Post hoc analysis of the Cluster Randomized Usual Care versus Caduet Investigation Assessing Long-term risk (CRUCIAL) trial.

Hradec J, Zamorano J, Sutradhar S.

Curr Med Res Opin. 2013 Jun;29(6):589-96. doi: 10.1185/03007995.2013.783795. Epub 2013 Apr 3.

PMID:
23464930
2.

Proactive cardiovascular risk management versus usual care in patients with and without diabetes mellitus: CRUCIAL trial subanalysis.

Kim JH, Zamorano J, Erdine S, Pavia A, Al-Khadra A, Sutradhar S, Yunis C; CR UCIAL Investigators.

Postgrad Med. 2012 Jul;124(4):41-53. doi: 10.3810/pgm.2012.07.2565.

PMID:
22913893
3.

Reduction in cardiovascular risk using proactive multifactorial intervention versus usual care in younger (< 65 years) and older (≥ 65 years) patients in the CRUCIAL trial.

Kim JH, Zamorano J, Erdine S, Pavia A, Al-Khadra A, Sutradhar S, Yunis C; CRUCIAL Investigators.

Curr Med Res Opin. 2013 May;29(5):453-63. doi: 10.1185/03007995.2013.781503. Epub 2013 Apr 3.

PMID:
23448581
4.

Changes in calculated coronary heart disease risk using proactive multifactorial intervention versus continued usual care in Latin-American and non-Latin-American patients enrolled in the CRUCIAL trial.

Pavia A, Zamorano J, Sutradhar S, Yunis C; CRUCIAL Investigators.

Curr Med Res Opin. 2012 Oct;28(10):1667-76. doi: 10.1185/03007995.2012.725391. Epub 2012 Sep 19.

PMID:
22991979
5.

Reduction in cardiovascular risk using a proactive multifactorial intervention is consistent among patients residing in Pacific Asian and non-Pacific Asian regions: a CRUCIAL trial subanalysis.

Cho EJ, Kim JH, Sutradhar S, Yunis C, Westergaard M; CRUCIAL trial investigators.

Vasc Health Risk Manag. 2014 Mar 26;10:145-56. doi: 10.2147/VHRM.S54586. eCollection 2014.

6.

Single-pill amlodipine/atorvastatin helps patients of diverse ethnicity attain recommended goals for blood pressure and lipids (the Gemini-AALA study).

Erdine S, Ro YM, Tse HF, Howes LG, Aguilar-Salinas CA, Chaves H, Guindy R, Chopra P, Moller RA, Schou IM; Gemini-AALA Investigators.

J Hum Hypertens. 2009 Mar;23(3):196-210. doi: 10.1038/jhh.2008.114. Epub 2008 Sep 18.

PMID:
18800143
8.

Proactive multiple cardiovascular risk factor management compared with usual care in patients with hypertension and additional risk factors: the CRUCIAL trial.

Zamorano J, Erdine S, Pavia A, Kim JH, Al-Khadra A, Westergaard M, Sutradhar S, Yunis C; CRUCIAL Investigators.

Curr Med Res Opin. 2011 Apr;27(4):821-33. doi: 10.1185/03007995.2011.555754. Epub 2011 Feb 10.

PMID:
21306285
9.

Design and rationale of a real-life study to compare treatment strategies for cardiovascular risk factors: the CRUCIAL study.

Zamorano J, Erdine S, Lopez AP, Kim JH, Al Khadra A, Westergaard M, Sutradhar S, Yunis C; CRUCIAL Investigators.

Postgrad Med. 2010 Mar;122(2):7-15. doi: 10.3810/pgm.2010.03.2117.

PMID:
20203451
10.
11.

Slovak trial on cardiovascular risk reduction following national guidelines with CaDUET® (the STRONG DUET study).

Fedacko J, Pella D, Jarcuska P, Sabol F, Kmec J, Lopuchovsky T, Merkovska L, Jedlickova L, Janicko M, Sajty M.

Adv Ther. 2013 Jan;30(1):60-70. doi: 10.1007/s12325-012-0075-z. Epub 2013 Jan 15.

PMID:
23328937
12.
13.

Atorvastatin calcium plus amlodipine for the treatment of hypertension.

Delgado-Montero A, Zamorano JL.

Expert Opin Pharmacother. 2012 Dec;13(18):2673-85. doi: 10.1517/14656566.2012.742064. Epub 2012 Nov 10. Review.

PMID:
23140185
14.

Improved attainment of blood pressure and cholesterol goals using single-pill amlodipine/atorvastatin in African Americans: the CAPABLE trial.

Flack JM, Victor R, Watson K, Ferdinand KC, Saunders E, Tarasenko L, Jamieson MJ, Shi H, Bruschi P.

Mayo Clin Proc. 2008 Jan;83(1):35-45. doi: 10.4065/83.1.35.

PMID:
18174006
15.

[One year persistence of atorvastatin and amlodipine fixed dose combination versus atorvastatin therapy].

Simonyi G, Ferenci T.

Orv Hetil. 2016 Mar 13;157(11):425-9. doi: 10.1556/650.2016.30401. Hungarian.

PMID:
26947091
16.
18.

Single-pill therapy in the treatment of concomitant hypertension and dyslipidemia (the amlodipine/atorvastatin gemini study).

Blank R, LaSalle J, Reeves R, Maroni J, Tarasenko L, Sun F.

J Clin Hypertens (Greenwich). 2005 May;7(5):264-73.

19.

Fixed combination of amlodipine and atorvastatin in cardiovascular risk management: patient perspectives.

Devabhaktuni M, Bangalore S.

Vasc Health Risk Manag. 2009;5(1):377-87. Review.

20.

Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD.

Koren MJ, Davidson MH, Wilson DJ, Fayyad RS, Zuckerman A, Reed DP; ALLIANCE Investigators.

Am J Kidney Dis. 2009 May;53(5):741-50. doi: 10.1053/j.ajkd.2008.11.025. Epub 2009 Feb 11.

PMID:
19216014

Supplemental Content

Support Center